- Report
- October 2025
- 135 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- August 2025
- 123 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- August 2025
- 136 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- June 2025
- 145 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- December 2025
- 200 Pages
Global
From €2688EUR$2,990USD£2,333GBP
- Report
- January 2026
- 195 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 100 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- December 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- November 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- June 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- August 2025
- 262 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- March 2026
- 370 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- February 2026
- 295 Pages
Global
From €2247EUR$2,500USD£1,951GBP
- Report
- March 2026
- 374 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 196 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- January 2026
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 194 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 196 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 186 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more